3 Stocks Improving Performance Of The Health Care Sector

TheStreet highlights 3 stocks pushing the health care sector higher today.
By TheStreet Wire ,

One out of the three major indices are trading lower today with the

Dow Jones Industrial Average

(

^DJI

) trading down 35 points (-0.2%) at 18,458 as of Tuesday, July 26, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,840 issues advancing vs. 1,054 declining with 156 unchanged.

The Health Care sector currently sits up 0.3% versus the S&P 500, which is unchanged. Top gainers within the sector include

Waters

(

WAT

), up 4.4%, and

Novo Nordisk A/S

(

NVO

), up 1.9%. A company within the sector that fell today was

AstraZeneca

(

AZN

), up 1.0%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3.

Baxter International

(

BAX

) is one of the companies pushing the Health Care sector higher today. As of noon trading, Baxter International is up $1.46 (3.2%) to $47.56 on light volume. Thus far, 2.7 million shares of Baxter International exchanged hands as compared to its average daily volume of 9.8 million shares. The stock has ranged in price between $46.47-$47.80 after having opened the day at $46.55 as compared to the previous trading day's close of $46.10.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. Baxter International has a market cap of $25.6 billion and is part of the health services industry. Shares are up 20.8% year-to-date as of the close of trading on Monday. Currently there is 1 analyst who rates Baxter International a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates

Baxter International

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, notable return on equity and attractive valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Baxter International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Medtronic

(

MDT

) is up $0.91 (1.1%) to $87.83 on light volume. Thus far, 1.6 million shares of Medtronic exchanged hands as compared to its average daily volume of 5.2 million shares. The stock has ranged in price between $86.55-$87.89 after having opened the day at $86.57 as compared to the previous trading day's close of $86.92.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medtronic plc manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $121.5 billion and is part of the health services industry. Shares are up 13.0% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate Medtronic a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates

Medtronic

as a

buy

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and reasonable valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Medtronic Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Allergan

(

AGN

) is up $1.94 (0.8%) to $249.79 on light volume. Thus far, 1.1 million shares of Allergan exchanged hands as compared to its average daily volume of 3.6 million shares. The stock has ranged in price between $246.82-$250.75 after having opened the day at $247.47 as compared to the previous trading day's close of $247.85.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. Allergan has a market cap of $98.5 billion and is part of the drugs industry. Shares are down 20.7% year-to-date as of the close of trading on Monday. Currently there are 11 analysts who rate Allergan a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates

Allergan

as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

Allergan Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

Loading ...